These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 6452654

  • 21. Quantitative bone scintigraphy in evaluating treatment of renal osteodystrophy.
    De Graaf P, Schicht IM, Te Velde J, Pauwels EK, Kleiverda K, De Graeff J.
    Neth J Med; 1983; 26(5):125-9. PubMed ID: 6408495
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Extraosseous accumulation of 99mTc-phosphate complexes (author's transl)].
    Takebayashi S, Ono Y, Odagiri K, Nakamori A, Asakura K, Matsui K, Tanaka T, Oikawa Y, Yamamoto Y.
    Kaku Igaku; 1981 Nov; 18(9):1207-15. PubMed ID: 6461788
    [No Abstract] [Full Text] [Related]

  • 25. Tumoral calcinosis-like metastatic calcification in a patient with renal osteodystrophy: CT and scintigraphic appearances.
    Kobayashi H, Hosono M, Fujimoto R, Konishi J.
    Clin Nucl Med; 1995 Dec; 20(12):1112-4. PubMed ID: 8674312
    [No Abstract] [Full Text] [Related]

  • 26. Prominent Tc-99m MIBI skeletal uptake in renal osteodystrophy: a possible role for whole-body scanning.
    Reczek J, Elgazzar A.
    Clin Nucl Med; 2003 Sep; 28(9):775-7. PubMed ID: 12973007
    [Abstract] [Full Text] [Related]

  • 27. Scintigraphic skeletal changes in non-dialyzed patients with advanced renal failure.
    Olgaard K, Madsen S, Heerfordt J, Hammer M, Jensen H.
    Clin Nephrol; 1979 Dec; 12(6):273-8. PubMed ID: 527281
    [Abstract] [Full Text] [Related]

  • 28. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer].
    Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 May 25; 42(5):454-66. PubMed ID: 6217442
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Value and limitations of scintigraphy based on methylene diphosphonate pyrophosphate labeled with 99m technetium in the monitoring of revascularized bone transplants].
    Clouet M, Chavoin JP, Vigoni F, Pessey JJ, Costagliola M.
    Ann Chir Plast; 1981 May 25; 26(3):217-20. PubMed ID: 6458230
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Bone scintigraphy with Tc 99m MDP in the study of late complications of total hip prosthesis].
    Tarozzi C, Furno A, Fagioli G, Arguello JM, Miglietta A, Specchia L, Ruggieri N, Rimondi E, De Benedittis M, Galletti S.
    Chir Organi Mov; 1984 May 25; 69(1):57-64. PubMed ID: 6237892
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Factor analysis of bone mineral dynamics in patients with renal osteodystrophy].
    Koizumi Y, Okamura T, Fukuda T, Inoue Y, Oomura M, Ikeda H, Hata M, Oda J, Ochi H, Onoyama Y.
    Kaku Igaku; 1989 Jul 25; 26(7):829-34. PubMed ID: 2810901
    [Abstract] [Full Text] [Related]

  • 39. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent].
    Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr 25; 42(4):389-97. PubMed ID: 6214765
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.